PRESS RELEASES

May 2026
Catalonia, Madrid, and Andalusia lead the way in rare disease research in Spain
Press Release_Report_Clinical Trials_2025_AELMHU.pdf

The Spanish Association of Laboratories for Orphan and Ultra-Orphan Drugs (AELMHU) has published the “Report on Clinical Trials for Rare Diseases in Spain 2025, ” which analyzes the most relevant data on clinical trials authorized for these conditions in 2025, as well as their evolution over the past six years in Spain.

Access the full press release here.

web2x-100

NEWSLETTER

Consent(Required)
(Required)
This field is a validation field and must remain unchanged.

  • AELMHU
  • C/ Paseo de la Castellana, 135 7th Floor 28046 Madrid
  • C/ Muntaner, 292, 1º 2ª
  • 08021 Barcelona

Subscribesubscribe to the

AELMHUNEWSLETTER

Consent(Required)
(Required)
This field is a validation field and must remain unchanged.

© 2026
Spanish Association of Orphan and Ultra-Orphan Drug Laboratories (AELMHU)